West Pharmaceutical Services, Inc. (BVMF:W2ST34)
Brazil flag Brazil · Delayed Price · Currency is BRL
34.50
-0.30 (-0.86%)
At close: Feb 3, 2026

BVMF:W2ST34 Ratios and Metrics

Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
93,993109,028146,722126,41892,112193,584
Market Cap Growth
-30.18%-25.69%16.06%37.24%-52.42%77.98%
Enterprise Value
91,607107,235145,590123,54789,843191,509
Last Close Price
34.5040.7156.0648.8337.1874.33
PE Ratio
34.5740.0948.1543.9129.7452.50
PS Ratio
5.556.448.208.836.0412.27
PB Ratio
5.376.238.849.046.4914.88
P/TBV Ratio
5.586.479.259.456.8115.78
P/FCF Ratio
36.3942.2285.8362.8639.65105.09
P/OCF Ratio
22.6126.2336.3133.5524.0759.49
EV/Sales Ratio
5.816.338.148.635.8912.14
EV/EBITDA Ratio
20.6524.0331.4330.1919.2238.58
EV/EBIT Ratio
27.3430.4839.6636.0522.2544.72
EV/FCF Ratio
35.4741.5285.1761.4338.68103.97
Debt / Equity Ratio
0.100.100.110.110.120.14
Debt / EBITDA Ratio
0.380.380.390.350.350.36
Debt / FCF Ratio
0.700.701.110.750.720.98
Net Debt / Equity Ratio
-0.15-0.15-0.07-0.19-0.21-0.19
Net Debt / EBITDA Ratio
-0.57-0.57-0.24-0.65-0.65-0.49
Net Debt / FCF Ratio
-0.99-0.99-0.65-1.31-1.31-1.32
Asset Turnover
0.780.780.770.790.830.93
Inventory Turnover
4.804.804.674.284.414.73
Quick Ratio
2.102.101.932.072.732.13
Current Ratio
3.023.022.802.883.702.93
Return on Equity (ROE)
16.86%16.86%17.71%21.32%23.34%31.59%
Return on Assets (ROA)
10.09%10.09%9.93%11.86%13.78%15.73%
Return on Invested Capital (ROIC)
18.85%19.66%20.14%26.35%31.89%38.14%
Return on Capital Employed (ROCE)
17.70%17.70%19.20%22.40%24.70%28.30%
Earnings Yield
2.89%2.49%2.08%2.28%3.36%1.91%
FCF Yield
2.75%2.37%1.17%1.59%2.52%0.95%
Dividend Yield
0.26%11.50%8.94%7.65%10.38%5.17%
Payout Ratio
12.40%12.40%12.00%9.61%9.23%7.72%
Buyback Yield / Dilution
1.36%1.36%2.13%0.66%0.66%-0.66%
Total Shareholder Return
1.62%12.86%11.06%8.31%11.04%4.51%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.